Lithium Carbonate Capsule
Product Images NDC 46708-304

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 46708-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150 mg 30's Bottle Pack (Lithium 150mg)

150 mg 30's Bottle Pack (Lithium 150mg)
This is a description of a medication called "Pama 0 Lithium Femima-Carbonate Smaedwiwen Capsules USP". It is packed in a container that is able to hold 500 units of USP Control Room temperature in order to protect it from moisture. The container has a total of 30 capsules each of which contains 500 USP. The medication was made by Hembe Pharmaceuticals and has a National Drug Code (NDC) of 46708-303-30. The container has been labeled with lot number "X" and there is a magnesium license number of G950 on it.*
FDA Label Image

300 mg 30's Bottle Pack (Lithium 300mg)

FDA Label Image

600 mg 30's Bottle Pack (Lithium 600mg)

600 mg 30's Bottle Pack (Lithium 600mg)
Each hard gelatin capsule contains Lithium Carbonate USP 600mg. The usual adult dose is either 300mg or 600mg taken three times a day. This information is not enough as there are some words that cannot be recognized.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.